In one study, the use of 5-FU plus oxaliplatin with CD1d-MC38/α-GC tumor vaccine that promotes DC maturation had synergistically delayed tumor growth rate and increased the survival time of tumor-bearing mice [316]. The gene discussed is CD1D; the disease is neoplasm.